Raymond James & Associates Phasebio Pharmaceuticals Inc C Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
BUY
N/A
15,500 New
15,500 $40,000

About PHASEBIO PHARMACEUTICALS INC C

PHASQ Quotes by TradingView
  • Ticker PHASQ
More about PHASQ
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email